Nursing management of a patient with calf muscle venous thrombosis complicated by bladder clot retention following oocyte retrieval: A case report
Abstract
Rationale: Venous thrombosis and hemorrhagic complications are rare but clinically significant risks during assisted reproductive treatments. This report describes comprehensive, evidence-based nursing interventions in a patient who developed calf muscle venous thrombosis and subsequent bladder hemorrhage with clot retention following oocyte retrieval.
Patient concerns: A female patient undergoing controlled ovarian hyperstimulation presented with calf discomfort and later experienced gross hematuria and clot retention after transvaginal oocyte retrieval.
Diagnoses: Intermuscular venous thrombosis of the calf with concurrent bladder hemorrhage.
Interventions: A multidisciplinary, real-time nursing risk management strategy was implemented. Key interventions included enhancing the patient's awareness of condition-related risks to promote active participation in care; continuous monitoring of bleeding risk through dynamic assessment of clinical indicators; strengthening acute-phase thrombosis management with early, evidence-based measures to prevent progression; optimizing bladder irrigation using a diluted hydrogen peroxide solution following careful evaluation of hemostatic and coagulation parameters; providing structured psychological support to address anxiety and emotional stress; and implementing phased, individualized follow-up nursing care after discharge, guided by Orem's self-care deficit nursing theory.
Outcomes: Bleeding was successfully controlled, and the patient…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.